Business Description
Asensus Surgical Inc
NAICS : 339112
SIC : 3841
ISIN : US89366M2017
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.71 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | -0.08 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -24.46 | |||||
Beneish M-Score | -3.51 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -8.9 | |||||
3-Year EBITDA Growth Rate | 23.5 | |||||
3-Year EPS without NRI Growth Rate | 26.9 | |||||
3-Year FCF Growth Rate | 26.9 | |||||
3-Year Book Growth Rate | -38.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.01 | |||||
9-Day RSI | 34.03 | |||||
14-Day RSI | 39.26 | |||||
6-1 Month Momentum % | 10.65 | |||||
12-1 Month Momentum % | -62.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.88 | |||||
Quick Ratio | 2.31 | |||||
Cash Ratio | 1.67 | |||||
Days Inventory | 222.34 | |||||
Days Sales Outstanding | 65.91 | |||||
Days Payable | 118.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.6 | |||||
Shareholder Yield % | -0.19 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -53.38 | |||||
Operating Margin % | -910.93 | |||||
Net Margin % | -914.46 | |||||
FCF Margin % | -748.37 | |||||
ROE % | -121.97 | |||||
ROA % | -93.2 | |||||
ROIC % | -228.5 | |||||
ROC (Joel Greenblatt) % | -429.85 | |||||
ROCE % | -107.29 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.09 | |||||
PB Ratio | 1.91 | |||||
Price-to-Tangible-Book | 2.01 | |||||
EV-to-EBIT | -0.64 | |||||
EV-to-EBITDA | -0.67 | |||||
EV-to-Revenue | 5.85 | |||||
EV-to-Forward-Revenue | 3.51 | |||||
EV-to-FCF | -0.78 | |||||
Price-to-Net-Current-Asset-Value | 6.03 | |||||
Earnings Yield (Greenblatt) % | -156.25 | |||||
FCF Yield % | -97.92 |